Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Bios Health
AddedMar 22, 2024
UpdatedJul 1, 2026
Bios Health

Bios Health

Series A

BIOS Health: Pioneering neural interfaces for medical advancements in the UK.

HQ
Cambridge, Cambridgeshire, GB
Founded
2015
Accelerator
Y Combinator logoY CombinatorW17
Overview
Compare
Fundraising
Employees
Website

Bios Health, originally known as Cambridge Bio-Augmentation Systems (CBAS), was founded with the mission to revolutionize medical treatments through advanced neural interfaces. The company focuses on decoding nerve data to develop precision medicine solutions. Their core products and services include AI-driven neural interfaces designed to understand and manipulate nerve signals for various medical applications. Bios Health aims to lead the market in neural treatments, leveraging cutting-edge technology to address complex neurological disorders.

Notable figures affiliated with Bios Health include experts in neuroscience, AI, and medical technology, although specific names are not provided. The company has attracted significant attention and investment from leading venture capital firms interested in healthcare innovation. Key achievements include pioneering advancements in neural interface technology and contributing to the emerging field of precision medicine. Bios Health's impact is profound, as it opens new possibilities for treating neurological conditions and enhancing the quality of life for patients worldwide.

Bios Health - Similar Companies

Precision Neuroscience logo

Precision Neuroscience

precisionneuro.io

BioAI Health logo

BioAI Health

bioaihealth.com

Neuralink logo

Neuralink

neuralink.com

BioHealthonomics logo

BioHealthonomics

Bionic Health logo

Bionic Health

bionichealth.com

Bionaut Labs logo

Bionaut Labs

bionautlabs.com

BioSensics logo

BioSensics

biosensics.com

Metabrain logo

Metabrain

Apex Neuro logo

Apex Neuro

Bioniq Health logo

Bioniq Health

AivoCode logo

AivoCode

aivocode.com

Endpoint Health logo

Endpoint Health

BioSens8 logo

BioSens8

biosens8.com

Wpss.Bio logo

Wpss.Bio

wpss.bio

ni2o logo

ni2o

ni2o.com

Bios Health - Quick Facts

Who are Bios Health's competitors?

Companies similar to Bios Health include Precision Neuroscience, BioAI Health, Neuralink and BioHealthonomics.

When was Bios Health founded?

Bios Health was founded in 2015.

Where is Bios Health's headquarters located?

Bios Health's headquarters is located in Cambridge, Cambridgeshire, GB.

When was Bios Health's last funding round?

Bios Health's most recent funding round was for $20M (USD) in June 2023.

How much has Bios Health raised to-date?

As of Jun 22, 2023, Bios Health has raised a total of $46.6M (USD).

How many employees does Bios Health have?

Bios Health has 40 employees as of Feb 24, 2024.

Bios Health - Classification

Ownership
  • Private Equity
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • Europe
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Neural Interfaces
Tags
  • Biotech
  • Healthtech
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software
Show 6 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7371Computer Programming Services